2024 annual financial data
Immunocore Holdings 2024 Financial results
Direct answer
Revenue was 247,983,620 USD.
Operating income was -56,280,019 USD and net income was -40,805,230 USD.
Operating cash flow was 26,061,000 USD.
Get free Immunocore Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 247,983,620 USD
- Operating income
- -56,280,019 USD
- Net income
- -40,805,230 USD
- Operating cash flow
- 26,061,000 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immunocore Holdings financial years